Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Soligenix Inc (NQ: SNGX )

3.360 -0.150 (-4.27%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Soligenix Inc

< Previous 1 2 Next >
Soligenix to Present at November 21st Virtual Investor Summit Microcap Event
Via ACCESSWIRE
Soligenix Announces Participation at the Spartan Capital Investor Conference
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Soligenix Announces Participation at the Spartan Capital Investor Conference
Premier Event to Showcase Growth Companies and Foster High-Level Investor Engagement 
Via TheNewswire.com
Nova Minerals and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESSWIRE
Soligenix and American Resources Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESSWIRE
MarketBeat Week in Review – 7/8 - 7/12
Stocks took investors on quite a ride this week, with the S&P 500 hitting a new record high, then falling back on Thursday before rallying to end the week 
Via MarketBeat
Topics Economy Stocks
Exposures Interest Rates US Equities
Uncover Why This Pharma Stock Jumped 400% on Study Update
Shares of Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, surged almost 400% today after announcing positive data. 
Via MarketBeat
Soligenix and Sharps Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESSWIRE
Soligenix and Mobilicom Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESSWIRE
ASP Isotopes and Soligenix Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
Via ACCESSWIRE
SPI Energy and Soligenix Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
Via ACCESSWIRE
Knightscope, Soligenix, and Genetic Technologies Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
Via ACCESSWIRE
BioVie and Soligenix Interviews to Air on the RedChip Money Report(R) on Bloomberg TV
Via ACCESSWIRE
Soligenix, Inc. CEO is Featured in an Interview with SmallCaps Daily
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures COVID-19
Soligenix, and Graphex Group Interviews to Air on Bloomberg TV on the RedChip Money Report(R)
Via ACCESSWIRE
Soligenix (NASDAQ: SNGX) Reports Strong Clinical Results from Compatibility Study of HyBryte as a Treatment for Cutaneous T-Cell Lymphoma
Soligenix, Inc. (NASDAQ: SNGX) is engaged as a late-stage biopharmaceutical company that is focused on the research, development and commercialization 
Via Spotlight Growth
Exposures Product Safety
Global Breast Cancer Market Size Projected To Hit $70 Billion in Revenues By 2030
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:BMY),(NASDAQ:NNOX),(NASDAQ:SNGX),(NASDAQ:CRDF) EQNX::TICKER_END 
Via FinancialNewsMedia
Soligenix, Inc: Vital Vaccine Development Program has Potential to Address Future Marburg Virus Outbreaks
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Death
Exposures Death
Soligenix On Track to Deliver Important Front-Line Treatment to US Market in 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Soligenix Delivers Two Pivotal Milestones
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Soligenix Positioned for Growth: Late-stage Pipeline and Key Q4 Milestones
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
UPDATE: Soligenix, Inc. to Showcase 2022 Milestones in Business Update Fireside Chat with PCG Advisory
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures Product Safety
Soligenix, Inc. to Showcase 2022 Milestones in Business Update Fireside Chat With PCG Advisory
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures Product Safety
Soligenix Enters Q4 With Multiple Catalysts in Play
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures Product Safety
FDA Awards $2.6 Million Grant for Expanded Study of Soligenix's HyBryte for CTCL
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures Product Safety
Soligenix's HyBryte Treatment Now Within Reach for Rare Cancer Patients
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures Product Safety
Soligenix Moves Forward with Treatments for Cutaneous T-Cell Lymphoma and Psoriasis
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Soligenix, Inc. (NASDAQ: SNGX) Developing Treatments for Multiple Cancers, Vaccine Candidates (Ebola, Sudan, & Marburg)
Via Get News
Exposures COVID-19
Soligenix, Inc. (NASDAQ: SNGX) Featured in Coverage of Investor Summit Group’s Q1 Virtual Event
Via Investor Brand Network
Soligenix, Inc. (NASDAQ: SNGX) Featured in Coverage of Investor Summit Group’s Q1 Virtual Event
Via CryptoCurrencyWire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.